Semaglutide and liraglutide linked to lower alcohol-related hospitalization risk

A recent study published in JAMA Psychiatry has uncovered promising evidence suggesting that glucagon-like peptide-1 (GLP-1) receptor agonists, particularly semaglutide and liraglutide, may be effective treatments for alcohol use disorder. These medications, originally developed to treat type 2 diabetes and…